Skip to main content
PACSPACS Group, Inc.Sell5.6·$40.05
PACS · Decision

Should you buy PACS Group (PACS)?

Updated

PACS Group delivers excellent cash conversion of 124% free cash flow relative to net income and a return on equity of 27%, with 18% analyst upside, but carries high leverage at debt-to-equity of 3.4 and two consecutive earnings misses that challenge the growth thesis heading into the next earnings cycle.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
5.6/10
Price
$40.05
Entry / Take Profit (TP) / Stop Loss (SL)
/ $43.21 / $37.28

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

PACS Group converts 124% of net income into free cash flow and generates a return on equity of 27%, indicating strong underlying cash generation relative to reported earnings and efficient use of equity capital.

Stable
Quality breakdown
Expectation
Free cash flow conversion remains above 80% of net income and return on equity stays above 20% for at least 3 of the next 4 reporting periods.

CounterHigh free cash flow conversion in healthcare facilities often reflects deferred capital expenditure on physical plant; if maintenance investment is normalized, conversion ratios may decline sharply.

The growth score shows strong earnings growth components at the maximum level, supporting the bull case for a strong growth profile in the skilled nursing and post-acute care market.

Stable
Bull case
Expectation
Revenue growth remains above 10% year-over-year for at least 3 of the next 4 quarters.

CounterPost-acute care operators face reimbursement rate risk from Medicare and Medicaid, which set pricing; a policy change or rate cut could stall growth regardless of operational quality.

A debt-to-equity ratio of 3.4 applies a leverage penalty to the score and limits the financial flexibility to invest in capacity expansion or withstand a revenue shortfall without covenant risk.

Stable
Bear case
Expectation
Debt-to-equity declines below 2.5 within 12 months as free cash flow is applied to debt reduction.

CounterHealthcare facilities regularly operate with leverage ratios above 3x due to real estate-intensive business models; the debt load may be structurally appropriate and not a constraint on growth.

▸ Show 1 more pillar

The two most recent quarters both missed earnings estimates — negative 3.8% and negative 5.0% respectively — indicating a potential pattern of elevated guidance-setting or operating cost pressure that is reducing execution reliability.

Stable
Earnings
Expectation
The company beats consensus earnings estimates in at least 2 of the next 4 quarters, recovering from the consecutive miss pattern.

CounterThe two quarters before the misses both produced substantial beats of 57% and 26%, suggesting the earnings trajectory remains strong and the misses may reflect a one-time reset period.

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1PACS Group converts 124% of net income into free cash flow and generates a return on equity of 27%, indicating strong underlying cash generation relative to reported earnings and efficient use of equity capital.

    Trip ifFree cash flow conversion falls below 50% of net income for 2 consecutive quarters.

  • P2The growth score shows strong earnings growth components at the maximum level, supporting the bull case for a strong growth profile in the skilled nursing and post-acute care market.

    Trip ifRevenue growth falls below 5% year-over-year for 2 consecutive quarters.

  • P3A debt-to-equity ratio of 3.4 applies a leverage penalty to the score and limits the financial flexibility to invest in capacity expansion or withstand a revenue shortfall without covenant risk.

    Trip ifDebt-to-equity ratio rises above 4.5 in any reporting period.

  • P4The two most recent quarters both missed earnings estimates — negative 3.8% and negative 5.0% respectively — indicating a potential pattern of elevated guidance-setting or operating cost pressure that is reducing execution reliability.

    Trip ifEPS surprise falls below 0% in at least 3 of the next 4 quarters.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for PACS Group, Inc. (PACS) is SELL_IF_HOLDING with medium conviction, score 5.6/10 at $40.05. The F-path SELL output reflects an overall score of 4.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of 0.52 is supplementary context, not the trigger.

2. What would change the verdict

The dominant failed gate is reward-to-risk at 0.5 vs threshold 1.5. SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:6.8>=5.5.

3. What the engine sees

On the bull side: Strong growth profile. On the bear side: Thin upside margin: 7.8%; Leverage penalty (D/E 3.4): -1.5; Consecutive earnings misses (2). Active engine warnings: V9 Gate Failed: ASYMMETRY:0.5<1.5@spot.

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $40.05, with structural invalidation at $37.28. The asymmetric R:R against a reversal hypothesis is 1.11 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates PACS — 10-dimension breakdown →

Bull case

  • Strong growth profile

Bear case

  • Thin upside margin: 7.8%
  • Leverage penalty (D/E 3.4): -1.5
  • Consecutive earnings misses (2)
Home Stocks PACS Buy or sell?